ASTRIA THERAPEUTICS INC (ATXS) Stock Earnings & Estimates
NASDAQ:ATXS - US04635X1028 - Common Stock
7.52 USD
+0.52 (+7.43%)
7.59 USD
+0.07 (+0.93%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 500K | -100.00% | 11.22M | 2.21M -80.30% | 3.04M 37.56% | 85.338M 2,707.17% | 280.69M 228.92% | 494.99M 76.35% | 733.41M 48.17% | 922.74M 25.82% | |||||||||
| EBITDA YoY % growth | -31.46M -46.80% | -35.16M -11.76% | -26.79M 23.81% | N/A 2.02% | N/A -3.09% | -35.904M -32.68% | -197.982M -451.42% | -52.938M 73.26% | -71.298M -34.68% | -114.24M -60.23% | -162.282M -42.05% | -182.784M -12.63% | -200.226M -9.54% | -209.712M -4.74% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.66M -46.03% | -35.56M -12.32% | -27.09M 23.82% | -27.475M 2.66% | -28.27M -2.73% | -38.148M -38.21% | -197.657M -420.78% | -54M 72.56% | -80.417M -26.79% | -115.558M -64.46% | -138.025M -23.72% | -159.606M -15.64% | -163.351M -2.35% | -129.104M 20.97% | 4.677M 103.62% | 134.33M 2,772.14% | 266.93M 98.71% | 415.86M 55.79% | |
| Operating Margin | N/A | N/A | -5,418.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -1,230.17% | -7,222.01% | -5,373.40% | -151.29% | 1.67% | 27.14% | 36.40% | 45.07% | |
| EPS YoY % growth | N/A | -133.80 42.05% | -76.80 42.60% | -30.15 46.09% | -14.78 65.94% | -11.51 13.62% | -39.19 -17.49% | -3.58 74.63% | -2.32 33.33% | -1.69 40.91% | -2.17 -51.74% | -2.32 -6.79% | -2.39 -3.31% | -1.58 33.85% | -0.34 78.53% | 0.72 311.01% | 2.61 263.29% | 4.08 56.56% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.40 5.36% | -0.56 -181.74% | -0.59 -2.09% | -0.60 -5.67% | -0.63 -58.77% | -0.65 -14.86% | -0.79 -33.16% | -0.65 -7.54% | -0.69 -8.77% | -0.72 -11.90% |
| Revenue Q2Q % growth | 10.88M | 3.06M | 1.02M | 1.02M | 510K -95.31% | 510K -83.33% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -41.106M -35.23% | -46.92M -52.82% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -24.421M 15.83% | -34.484M -16.54% | -37.259M -0.71% | -37.74M -5.36% | -39.658M -62.39% | -40.538M -17.56% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.57 -32.56% | -0.60 | 0.03 | 4.64% |
| Q1 2025 Q2Q % growth | -0.58 -52.63% | -0.49 | -0.09 | -18.75% |
| Q4 2024 Q2Q % growth | -0.20 78.72% | -0.46 | 0.26 | 56.57% |
| Q3 2024 Q2Q % growth | -0.42 33.33% | -0.43 | 0.01 | 2.33% |
| Q2 2024 Q2Q % growth | -0.43 4.44% | -0.39 | -0.04 | -9.50% |
| Q1 2024 Q2Q % growth | -0.38 5.00% | -0.37 | -0.01 | -2.35% |
| Q4 2023 Q2Q % growth | -0.94 -30.56% | -0.80 | -0.14 | -18.12% |
| Q3 2023 Q2Q % growth | -0.63 27.59% | -0.50 | -0.13 | -27.09% |
| Q2 2023 Q2Q % growth | -0.45 47.67% | -0.50 | 0.05 | 9.44% |
| Q1 2023 Q2Q % growth | -0.40 66.10% | -0.56 | 0.16 | 28.94% |
| Q4 2022 Q2Q % growth | -0.72 93.45% | -0.73 | 0.01 | 0.81% |
| Q3 2022 Q2Q % growth | -0.87 -42.62% | -0.94 | 0.07 | 7.09% |
| Q2 2022 Q2Q % growth | -0.86 31.75% | -1.04 | 0.18 | 16.93% |
| Q1 2022 Q2Q % growth | -1.18 18.06% | -0.74 | -0.44 | -58.91% |
| Q4 2021 Q2Q % growth | -11.00 -316.67% | -0.67 | -10.33 | -1,533.99% |
| Q3 2021 Q2Q % growth | -0.61 81.85% | -0.79 | 0.18 | 22.58% |
| Q2 2021 Q2Q % growth | -1.26 60.38% | -1.86 | 0.60 | 32.13% |
| Q1 2021 Q2Q % growth | -1.44 52.00% | -0.94 | -0.50 | -53.46% |
| Q4 2020 Q2Q % growth | -2.64 20.00% | -2.26 | -0.38 | -16.59% |
| Q3 2020 Q2Q % growth | -3.36 | -3.12 | -0.24 | -7.65% |
| Q2 2020 Q2Q % growth | -3.18 14.52% | -2.78 | -0.40 | -14.20% |
| Q1 2020 Q2Q % growth | -3.00 19.35% | -2.51 | -0.49 | -19.56% |
| Q4 2019 Q2Q % growth | -3.30 | -3.76 | 0.46 | 12.32% |
| Q3 2019 Q2Q % growth | -3.36 | -3.89 | 0.53 | 13.72% |
| Q2 2019 Q2Q % growth | -3.72 | -3.71 | -0.01 | -0.19% |
| Q1 2019 Q2Q % growth | -3.72 | -4.25 | 0.53 | 12.54% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 35.14% | 17.73% | 3.73% | 1.5% |
| Revenue | N/A | N/A | N/A | N/A |